Literature DB >> 23044665

Identification and characterization of kidney transplants with good glomerular filtration rate at 1 year but subsequent progressive loss of renal function.

Walter D Park1, Timothy S Larson, Matthew D Griffin, Mark D Stegall.   

Abstract

BACKGROUND: After the first year after kidney transplantation, 3% to 5% of grafts fail each year but detailed studies of how grafts progress to failure are lacking. This study aimed to analyze the functional stability of kidney transplants between 1 and 5 years after transplantation and to identify initially well-functioning grafts with progressive decline in allograft function.
METHODS: The study included 788 adult conventional kidney transplants performed at the Mayo Clinic Rochester between January 2000 and December 2005 with a minimum graft survival and follow-up of 2.6 years. The modification of diet in renal disease equation for estimating glomerular filtration rate (eGFR(MDRD)) was used to calculate the slope of renal function over time using all available serum creatinine values between 1 and 5 years after transplantation.
RESULTS: Most transplants demonstrated good function (eGFR(MDRD) ≥40 mL/min) at 1 year with positive eGFR(MDRD) slope between 1 and 5 years after transplantation. However, a subset of grafts with 1-year eGFR(MDRD) ≥40 mL/min exhibited strongly negative eGFR(MDRD) slope between 1 and 5 years suggestive of progressive loss of graft function. Forty-one percent of this subset reached graft failure during follow-up, accounting for 69% of allograft failures occurring after 2.5 years after transplantation. This pattern of progressive decline in estimated glomerular filtration rate despite good early function was associated with but not fully attributable to factors suggestive of enhanced antidonor immunity.
CONCLUSIONS: Longitudinal analysis of serial estimated glomerular filtration ratemeasurements identifies initially well-functioning kidney transplants at high risk for subsequent graft loss. For this subset, further studies are needed to identify modifiable causes of functional decline.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23044665      PMCID: PMC3907766          DOI: 10.1097/TP.0b013e3182692b70

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  26 in total

1.  Slope of changes in renal function in the first year post-transplantation and one-yr estimated glomerular filtration rate together predict long-term renal allograft survival.

Authors:  Jianyong Wu; Hui Li; Hongfeng Huang; Rending Wang; Yimin Wang; Qiang He; Jianghua Chen
Journal:  Clin Transplant       Date:  2010 Nov-Dec       Impact factor: 2.863

2.  Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation.

Authors:  H Ekberg; C Bernasconi; H Tedesco-Silva; S Vítko; C Hugo; A Demirbas; R Reyes Acevedo; J Grinyó; U Frei; Y Vanrenterghem; P Daloze; P Halloran
Journal:  Am J Transplant       Date:  2009-06-26       Impact factor: 8.086

3.  Estimating glomerular filtration rate in kidney transplant recipients: performance over time of four creatinine-based formulas.

Authors:  Fanny Buron; Aoumer Hadj-Aissa; Laurence Dubourg; Emmanuel Morelon; Jean-Paul Steghens; Michel Ducher; Jean-Pierre Fauvel
Journal:  Transplantation       Date:  2011-11-15       Impact factor: 4.939

4.  Fibrosis with inflammation at one year predicts transplant functional decline.

Authors:  Walter D Park; Matthew D Griffin; Lynn D Cornell; Fernando G Cosio; Mark D Stegall
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

5.  The relationship between kidney function and long-term graft survival after kidney transplant.

Authors:  Bertram L Kasiske; Ajay K Israni; Jon J Snyder; Melissa A Skeans
Journal:  Am J Kidney Dis       Date:  2011-01-22       Impact factor: 8.860

6.  Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study.

Authors:  Hallvard Holdaas; Lionel Rostaing; Daniel Serón; Edward Cole; Jeremy Chapman; Bengt Fellstrøm; Erik H Strom; Alan Jardine; Karsten Midtvedt; Uwe Machein; Bettina Ulbricht; Alexander Karpov; Philip J O'Connell
Journal:  Transplantation       Date:  2011-08-27       Impact factor: 4.939

7.  The histology of solitary renal allografts at 1 and 5 years after transplantation.

Authors:  M D Stegall; W D Park; T S Larson; J M Gloor; L D Cornell; S Sethi; P G Dean; M Prieto; H Amer; S Textor; T Schwab; F G Cosio
Journal:  Am J Transplant       Date:  2010-11-09       Impact factor: 8.086

8.  Five-year safety and efficacy of belatacept in renal transplantation.

Authors:  Flavio Vincenti; Gilles Blancho; Antoine Durrbach; Peter Friend; Josep Grinyo; Philip F Halloran; Jurgen Klempnauer; Philippe Lang; Christian P Larsen; Ferdinand Mühlbacher; Björn Nashan; Jean-Paul Soulillou; Yves Vanrenterghem; Thomas Wekerle; Mamta Agarwal; Sheila Gujrathi; Jinshan Shen; Rebecca Shi; Robert Townsend; Bernard Charpentier
Journal:  J Am Soc Nephrol       Date:  2010-07-15       Impact factor: 10.121

9.  Estimated glomerular filtration rate evolution between 6 and 24 months predicts long-term kidney transplant survival among patients with inferior graft function.

Authors:  M Magott-Procelewska; M Boratynska; D Janczak; P Chudoba; D Patrzałek; P Biecek; M Klinger
Journal:  Transplant Proc       Date:  2009-10       Impact factor: 1.066

10.  Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium.

Authors:  Pamala A Jacobson; David Schladt; Ajay Israni; William S Oetting; Yi Cheng Lin; Robert Leduc; Weihau Guan; Vishal Lamba; Arthur J Matas
Journal:  Transplantation       Date:  2012-03-27       Impact factor: 4.939

View more
  14 in total

1.  Restoration of renal function does not correct impairment of uremic HDL properties.

Authors:  Chantal Kopecky; Michael Haidinger; Ruth Birner-Grünberger; Barbara Darnhofer; Christopher C Kaltenecker; Gunther Marsche; Michael Holzer; Thomas Weichhart; Marlies Antlanger; Johannes J Kovarik; Johannes Werzowa; Manfred Hecking; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2014-07-28       Impact factor: 10.121

2.  Considerations for a Primary Care Physician Assistant in Treating Kidney Transplant Recipients.

Authors:  Ryan Aston; Allison Durkin; Kristen Harris; Amanda Mace; Sierra Moore; Brittany Smith; Eric Soult; Mara Wright; Dustin Yothers; Derrick L Latos; Joseph Horzempa
Journal:  Qual Prim Care       Date:  2015

3.  Predicting Individual Renal Allograft Outcomes Using Risk Models with 1-Year Surveillance Biopsy and Alloantibody Data.

Authors:  Manuel Moreno Gonzales; Andrew Bentall; Walter K Kremers; Mark D Stegall; Richard Borrows
Journal:  J Am Soc Nephrol       Date:  2016-03-09       Impact factor: 10.121

4.  Progressive decline of function in renal allografts with normal 1-year biopsies: Gene expression studies fail to identify a classifier.

Authors:  Walter D Park; Dean Y Kim; Martin L Mai; Kunam S Reddy; Thomas Gonwa; Margaret S Ryan; Loren P Herrera Hernandez; Maxwell L Smith; Xochiquetzal J Geiger; Sandor Turkevi-Nagy; Lynn D Cornell; Byron H Smith; Walter K Kremers; Mark D Stegall
Journal:  Clin Transplant       Date:  2021-11-09       Impact factor: 2.863

5.  The role of sildenafil in the development of transplant arteriosclerosis in rat aortic grafts.

Authors:  Shuai Luo; Mei Yang; Hao Jin; Zi-Qiang Xu; Yi-Fu Li; Peng Xia; Yi-Rrong Yang; Bi-Cheng Chen; Yan Zhang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

6.  Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.

Authors:  Julio Pascual; Stefan P Berger; Oliver Witzke; Helio Tedesco; Shamkant Mulgaonkar; Yasir Qazi; Steven Chadban; Federico Oppenheimer; Claudia Sommerer; Rainer Oberbauer; Yoshihiko Watarai; Christophe Legendre; Franco Citterio; Mitchell Henry; Titte R Srinivas; Wen-Lin Luo; AnaMaria Marti; Peter Bernhardt; Flavio Vincenti
Journal:  J Am Soc Nephrol       Date:  2018-05-11       Impact factor: 10.121

Review 7.  Through a glass darkly: seeking clarity in preventing late kidney transplant failure.

Authors:  Mark D Stegall; Robert S Gaston; Fernando G Cosio; Arthur Matas
Journal:  J Am Soc Nephrol       Date:  2014-08-05       Impact factor: 10.121

8.  A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.

Authors:  Farsad Eskandary; Heinz Regele; Lukas Baumann; Gregor Bond; Nicolas Kozakowski; Markus Wahrmann; Luis G Hidalgo; Helmuth Haslacher; Christopher C Kaltenecker; Marie-Bernadette Aretin; Rainer Oberbauer; Martin Posch; Anton Staudenherz; Ammon Handisurya; Jeff Reeve; Philip F Halloran; Georg A Böhmig
Journal:  J Am Soc Nephrol       Date:  2017-12-14       Impact factor: 10.121

Review 9.  Chronic Allograft Injury.

Authors:  Eric Langewisch; Roslyn B Mannon
Journal:  Clin J Am Soc Nephrol       Date:  2021-04-05       Impact factor: 8.237

10.  Everolimus-facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2-year results from the subgroup analysis of the TRANSFORM study.

Authors:  Yoshihiko Watarai; Romina Danguilan; Concesa Casasola; Shen-Shin Chang; Prajej Ruangkanchanasetr; Terence Kee; Hin Seng Wong; Takashi Kenmochi; Angel Joaquin Amante; Kuo-Hsiung Shu; Atiporn Ingsathit; Peter Bernhardt; Maria Pilar Hernandez-Gutierrez; Duck Jong Han; Myoung Soo Kim
Journal:  Clin Transplant       Date:  2021-09-23       Impact factor: 3.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.